R-S-V season is just around the corner, and new research suggests vaccinating adults over 70 could be the best way to use public dollars. Health reporter Katherine Ward has more on why researchers say this is a cost-effective strategy.
Health Matters
RSV vaccines cost-effective in adults 70+
More Videos
-
Health Matters: CMA calls for health spending tracking
-
Health Matters: Canadians urged to get second mpox dose amid global rise in cases
-
Health Matters: NL becomes 1st province to sign onto National School Food Program
-
Health Matters: Canada issues Oropouche travel advisory
-
Health Matters: Federal health spending has outpaced provinces
You are viewing an Accelerated Mobile Webpage.
View Original Article